Lista de obras -

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.

artículo científico publicado en 2015

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

artículo científico publicado en 2019

AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel

artículo científico publicado en 2019

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

artículo científico publicado en 2016

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus

artículo científico publicado en 2010

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer

scientific article published on 27 February 2019

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

artículo científico publicado en 2008

Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer

artículo científico publicado en 2005

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

artículo científico publicado en 2008

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

artículo científico publicado en 2018

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2019

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

artículo científico publicado en 2016

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations

artículo científico publicado en 2013

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

artículo científico publicado en 2013

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes ⬇️

artículo científico publicado el 24 de diciembre de 2011

Circulating tumour cell detection on its way to routine diagnostic implementation?

artículo científico publicado en 2007

Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy

artículo científico publicado en 2015

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

artículo científico publicado en 2010

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

scientific article published on 07 January 2014

Complex landscapes of somatic rearrangement in human breast cancer genomes

artículo científico publicado en 2009

Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer

scientific article published on 03 May 2007

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

artículo científico publicado en 2018

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes ⬇️

artículo científico publicado el 12 de julio de 2011

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells

artículo científico publicado en 2015

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

artículo científico publicado en 2007

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

artículo científico publicado en 2015

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

artículo científico publicado en 2010

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

artículo científico publicado en 2011

Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts

artículo científico publicado en 2002

Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature

artículo científico publicado en 2004

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

artículo científico publicado en 2009

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer

artículo científico publicado en 2008

Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers

artículo científico publicado en 2014

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.

artículo científico publicado en 2014

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

artículo científico publicado en 2008

Functional Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

article

GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.

artículo científico publicado en 2016

Genes associated with breast cancer metastatic to bone

artículo científico publicado en 2006

Genomic Evolution of Breast Cancer Metastasis and Relapse

artículo científico

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study

artículo científico publicado en 2007

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

artículo científico publicado en 2017

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes ⬇️

artículo científico publicado el 11 de septiembre de 2012

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study

artículo científico publicado en 2005

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

artículo científico publicado en 2009

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer

artículo científico publicado en 2015

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

artículo científico publicado en 2015

KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival ⬇️

artículo científico publicado el 23 de enero de 2013

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue ⬇️

artículo científico publicado el 9 de febrero de 2013

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.

artículo científico publicado en 2014

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

artículo científico publicado en 2016

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

artículo científico publicado en 2013

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

artículo científico publicado en 2010

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer

artículo científico publicado en 2016

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

artículo científico publicado en 2005

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

artículo científico publicado en 2006

Multiplex molecular analysis of CTCs.

artículo científico publicado en 2012

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

article

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

artículo científico publicado en 2007

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

artículo científico publicado en 2017

Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer

artículo científico publicado en 2008

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

scientific article published on 17 October 2016

Progressive APOBEC3B mRNA expression in distant breast cancer metastases.

artículo científico publicado en 2017

Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.

artículo científico publicado en 2015

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

artículo científico publicado en 2017

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

artículo científico publicado en 2009

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

artículo científico publicado en 2010

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

artículo científico publicado en 2015

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

artículo científico publicado en 2016

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

artículo científico publicado en 2008

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

artículo científico publicado en 2016

The Life History of 21 Breast Cancers

The challenge of gene expression profiling in heterogeneous clinical samples ⬇️

artículo científico publicado el 29 de mayo de 2012

The circular RNome of primary breast cancer

scientific article published on 28 January 2019

The topography of mutational processes in breast cancer genomes

artículo científico publicado en 2016

Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor

artículo científico publicado en 2007

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients

artículo científico publicado en 2006

Lista de obras de

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.

APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer

AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus

Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response

Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.

Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes ⬇️

Circulating tumour cell detection on its way to routine diagnostic implementation?

Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy

Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study.

Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer

Complex landscapes of somatic rearrangement in human breast cancer genomes

Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer

Confirmation of a metastasis-specific microRNA signature in primary colon cancer.

Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes ⬇️

DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cells

DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients

Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients

Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblasts

Differential expression of splicing variants of the human caldesmon gene (CALD1) in glioma neovascularization versus normal brain microvasculature

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer

Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers

Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

Functional Assay Reveals Homologous Recombination Deficiency in Breast Cancer Beyond BRCA Gene Defects

GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.

Genes associated with breast cancer metastatic to bone

Genomic Evolution of Breast Cancer Metastasis and Relapse

HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes ⬇️

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer

Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.

KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival ⬇️

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue ⬇️

LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy.

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.

MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer

Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling

Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.

Multiplex molecular analysis of CTCs.

Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer

Production of P-glycoprotein from the MDR1 upstream promoter is insufficient to affect the response to first-line chemotherapy in advanced breast cancer

Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor

Progressive APOBEC3B mRNA expression in distant breast cancer metastases.

Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes.

Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

The Life History of 21 Breast Cancers

The challenge of gene expression profiling in heterogeneous clinical samples ⬇️

The circular RNome of primary breast cancer

The topography of mutational processes in breast cancer genomes

Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor

Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients